RenovoRx Inc
RNXTLatest QuantConomy context for RNXT: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
RenovoRx Inc
QuantConomy has a structured record for RNXT. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- RNXT
- Name
- RenovoRx Inc
- Coverage
- 3 market/data records
- Sources
- alphavantage alpaca fmp sec nasdaq
Recent signals for RNXT
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| delisting | very bearish | 75 | Jul 2, 01:45 PM | RNXT filed 8-K: Delisting Notice - 1 material event - [strong very bearish signal] |
| other event | neutral | 40 | Jun 30, 09:50 PM | RNXT filed 8-K: Shareholder Vote Results - [weak neutral signal] |
| eps change | very bullish | 76 | May 14, 12:00 AM | RNXT (Q1 2026, diluted eps): EPS grew 71.9% ($-0.32 → $-0.09). [sequential period basis, very bullish signal] |
FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| RNXT | NASDAQ | alphavantage | RenovoRx Inc |
| RNXT | NASDAQ | alpaca | RenovoRx, Inc. Common Stock |
| RNXT | NASDAQ | fmp | RenovoRx, Inc. |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 19, 2026 | VOLL MARK | Chief Financial Officer | purchase | 25,000 | $0.79 | $19,690 | 4 on EDGAR |
| Apr 3, 2026 | VOLL MARK | Chief Financial Officer | grant | 80,000 | $0.00 | $0 | 4 on EDGAR |
| Apr 3, 2026 | Agah Ramtin | Chief Medical Officer | grant | 621,727 | — | — | 4 on EDGAR |
| Apr 3, 2026 | Bagai Shaun | Chief Executive Officer | grant | 946,107 | — | — | 4 on EDGAR |
| Apr 3, 2026 | Gentry Leesa | Chief Clinical Officer | grant | 128,550 | — | — | 4 on EDGAR |
| Mar 25, 2026 | VOLL MARK | Chief Financial Officer | grant | 12,380 | $0.00 | $0 | 4 on EDGAR |
| Mar 20, 2026 | Marton Laurence | Insider | purchase | 9,720 | — | — | 4 on EDGAR |
| Mar 20, 2026 | Bagai Shaun | Chief Executive Officer | purchase | 24,300 | — | — | 4 on EDGAR |
| Mar 20, 2026 | VOLL MARK | Chief Financial Officer | purchase | 97,200 | — | — | 4 on EDGAR |
| — | VOLL MARK | Chief Financial Officer | — | — | — | — | 3 on EDGAR |
| — | VOLL MARK | Chief Financial Officer | — | — | — | — | 3 on EDGAR |
| Jan 21, 2026 | Agah Ramtin | Chief Medical Officer | purchase | 10,000 | $1.00 | $9,975 | 4 on EDGAR |
| Dec 31, 2025 | Agah Ramtin | Chief Medical Officer | purchase | 9,795 | $0.86 | $8,424 | 4 on EDGAR |
| Dec 30, 2025 | Agah Ramtin | Chief Medical Officer | purchase | 205 | $0.83 | $169 | 4 on EDGAR |
| Dec 18, 2025 | Bagai Shaun | Chief Executive Officer | purchase | 5,000 | $0.90 | $4,507 | 4 on EDGAR |
| Dec 17, 2025 | Bagai Shaun | Chief Executive Officer | purchase | 5,000 | $0.85 | $4,262 | 4 on EDGAR |
| Dec 5, 2025 | Agah Ramtin | Chief Medical Officer | purchase | 10,000 | $0.96 | $9,600 | 4 on EDGAR |
| Nov 21, 2025 | Agah Ramtin | Chief Medical Officer | purchase | 10,000 | $0.80 | $8,000 | 4 on EDGAR |
| Mar 3, 2022 | RYAN UNA S | Insider | other | 47,789 | $4.19 | $200,236 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query RNXT context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access